Drug Profile
LAS 33441
Latest Information Update: 22 Aug 2001
Price :
$50
*
At a glance
- Originator Almirall-Prodesfarma
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported NSAID-induced ulcer
Most Recent Events
- 22 Aug 2001 No-Development-Reported for NSAID-induced ulcer in Spain (Unknown route)
- 28 Jan 1999 New profile
- 28 Jan 1999 Preclinical development for NSAID-induced ulcer in Spain (Unknown route)